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1. Introduction  
Folate, as a member of the water-soluble B-group vitamins, is found widely in foodstuffs. 
Folate cannot be synthesized by human therefore dietary intake is the only source for 
human to obtain folate. The pteropolyglumates, usually with 1~6 glutamic acid molecules, 
are the major forms of natural food folates (Lucock 2000) and the 5-methyl tetrahydrofolate 
(5-metTHF), derived from hydrolization of absorbed folate and folic acid (the synthetic form 
of folate) as well, is the primary form in circulation (Ulrich 2005; Pietrzik, Bailey et al. 2010). 
Through the transmembrane transportation, the 5-metTHF in cell can be reduced by 
dihydrafolate reductase to tetrahydrofolate (THF) that is directly involved in metabolic 
process (Lucock 2000; Pietrzik, Bailey et al. 2010), and then performs biological functions in 
several ways. THF can be metabolized to 5,10-methylene-THF and further be irreversibly 
reduced into 5-metTHF which is the key step in one-carbon unit metabolism that is 
catalyzed by the enzyme methylenetetrahydrofolate reductase (MTHFR). By using the 
methyl donated by 5-methyltetrahydrofolate, the enzyme methionine synthase (MS) 
converts homocystine to methionine and then the de novo synthesized methionine can be 
catalyzed by the methionine adenosyl transferase to yield S-adenosylmethionine which 
directly provides methyl for a variety of important in vivo methylation reactions (Lucock 
2000; Sanderson, Stone et al. 2007). By using 5,10-methylene-THF as methyl donor, the 
enzyme thymidylate synthase converts deoxyuridylate (dUMP) to deoxythymidylate 
(dTMP), meanwhile the 5,10-formyltetrahydrofolate from 5,10-methylene-THF is involved 
in the production of both adenosine and guanosine, all are physiological building blocks of 
DNA replication (Bollheimer, Buettner et al. 2005; Duthie 2011). Thus, the most prominent 
function of folate is to transfer and process the one-carbon unit which is needed for 
methylation reactions and synthesis of thymine and purines. Consequently, folate deficiency 
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may biologically implicated in physiological processes including base misincorporation and 
DNA strand breaks, insufficient de nove nucleotide synthesis, as well as impaired DNA 
repair and methylation (Lucock 2000; Ames 2001; Kim 2003; Sanderson, Stone et al. 2007; 
Duthie 2011).  
Therefore, folate has been implicated in colorectal cancer (CRC) because that the steps of 
folate metabolism may be involved in distinct biological process. A number of 
epidemiologic and experimental studies concluded that folate may have an inverse 
association with risk of CRC, however, the results are not consistent and it is argued that too 
much folate may be unfavourable for preventing the development of CRC especially in 
those with precursor lesions such as invisible minor adenoma (Giovannucci 2002; Sharp and 
Little 2004; Strohle, Wolters et al. 2005; Kim 2006; Sanderson, Stone et al. 2007; Sauer, Mason 
et al. 2009; Kennedy, Stern et al. 2011). The distinct effects of folate on the development of 
CRC in populations with diversely genetic background suggest that genetic factors, as well 
as the interaction with folate intake and other coenzymatical factors, may also play a role in 
the prevention or promotion of colorectal carcinogenesis (Giovannucci 2002; Sharp and 
Little 2004; Kim 2006; Arasaradnam, Commane et al. 2008; Hubner and Houlston 2009). 
Growing evidence revealed that the polymorphisms in key folate-metabolism genes may 
also modify CRC risk in relation to folate intake; but the results are not consistent. Studies 
suggested that several functional polymorphisms in key genes involved in folate 
metabolism, such as MS A2756G, MTHFR C677T and A1298C, may associate with risk of 
CRC (Giovannucci 2002; Sharp and Little 2004; Kim 2007; Sanderson, Stone et al. 2007; Yu, 
Zhang et al. 2010). For the MS gene, it is still debatable to what extent can the MS 2756G 
variant modulate enzyme activity and plasma homocysteine levels, though evidence from 
epidemiological studies suggests an association between MS A2756G polymorphism and 
risk of CRC (DeVos, Chanson et al. 2008; Yu, Zhang et al. 2010). To date, several published 
studies have investigated the role of the MS 2756G variant and its interaction with folate 
intake in the etiology of CRC, mainly in western but few in Chinese populations (Chen, 
Giovannucci et al. 1998; Ma, Stampfer et al. 1999; Goode, Potter et al. 2004; Ulvik, Vollset et 
al. 2004; Chen, Jiang et al. 2005; Matsuo, Ito et al. 2005; Ulrich, Curtin et al. 2005; Koushik, 
Kraft et al. 2006; Theodoratou, Farrington et al. 2008; Yamaji, Iwasaki et al. 2009; Yu, Zhang 
et al. 2010). For the MTHFR gene, the 677T variant encodes an enzyme that is thermolabile, 
and the heterozygous CT or homozygous TT genotype have nearly 35% or 70% reduction in 
normal function of the enzyme in vitro, respectively (Molloy, Daly et al. 1997). Similarly, the 
1298A>C change leads to a decrease in the enzyme activity reportedly in vitro, but to a lesser 
extent, compared with the 677T variant (Weisberg, Jacques et al. 2001). Although the 
association between MTHFR C677T or A1298C polymorphism and CRC risk has also been 
extensively investigated, the results are not consistent (Chen, Giovannucci et al. 1996; Ma, 
Stampfer et al. 1997; Chen, Giovannucci et al. 1998; Chen, Ma et al. 2002; Sharp and Little 
2004; Ulvik, Vollset et al. 2004; Matsuo, Ito et al. 2005; Huang, Han et al. 2007; Kim 2007).  
In addition, alcohol drinking, as one of the known risk factors for CRC, can interfere with 
the metabolism of folate and one-carbon unit and thus may alter CRC risk in subjects 
carrying different genotypes. Some earlier studies on folate intake reported that the 
favourable effects of folate or some genotypes (such as the MTHFR 677TT genotype) can be 
conversely modified by alcohol drinking (Giovannucci 2004; Mason and Choi 2005; Matsuo, 
Ito et al. 2005). Many, but not all, epidemiological studies further suggested that the 
interactions among folate intake, alcohol drinking and polymorphisms in genes involved in 
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folate metabolism are likely presented in the etiology of CRC risk, but the published results 
were not consistent (Giovannucci 2004; Mason and Choi 2005; Matsuo, Ito et al. 2005; Kim 
2007; Kim 2007). Several published studies have investigated the role of folate metabolizing 
gene polymorphisms and  their interactions with folate intake or alcohol drinking in the 
etiology of CRC, but few in Chinese populations. Therefore, we performed a case-control 
study to assess the effect of folate intake and some reported functional polymorphisms in 
genes involved in folate metabolism in the etiology of CRC in Chinese populations, either 
for their individual effects or the joint effects with alcohol consumption and tobacco 
smoking. 
2. Materials and methods 
2.1 Subjects 
All cases and controls were recruited from those who were registered into three hospitals of 
Chongqing City, Southwest China, between January 2001 and September 2004. All cases 
were newly diagnosed and histopathologically confirmed as having CRC, without any prior 
cancer history or any chemo-radiotherapies. Controls were cancer-free inpatients from those 
who had no other severe diseases (i.e., severe cardiovascular diseases, diabetes, severe 
hypertension, fatty liver and hepatocirrhosis), and without cancer history. Cases and 
controls were frequency matched by sex, age (±5 years), residence (the same city or county). 
All subjects were aged between 30-80 years and asked during personal interview to provide 
a one-time 2~5 ml peripheral blood sample and to complete a questionnaire that elicited 
information about lifestyles including alcohol drinking and tobacco smoking (1 year prior to 
the diagnosis for the cases and the time at recruitment for the controls). This study was 
approved by the Research Ethics Committee of The Third Military Medical University. All 
subjects provided a signed written informed consent or oral consent if illiterate. Finally, of a 
total of 1082 cases and 949 controls, we recruited 478 eligible cases (185 colon and 293 rectal 
cancer) and 838 eligible controls, who had consented to the present study, completed the 
questionnaires, and provided blood samples.  
2.2 Assessment of folate intake and alcohol consumption 
Information about folate intake and alcohol consumption one year prior to CRC diagnosis 
(for cases) or the reference date at recruitment (for controls) was obtained by using the 
119-item semi-quantitative food frequency questionnaire developed specifically for 
Chongqing middle-aged population in our previous work as described elsewhere (Zhou, 
Takezaki et al. 2004). Briefly, according to the folate content listed in China Food 
Composition 2002 (Institute of Nutrition and Food Safety. China Center of Disease 
Control 2002), the frequencies of consumed portion of each food were converted into 
nutrients; for example, a crude mean of daily folate intake was calculated by multiplying 
the daily various food intake by its folate content (per 100 grams). The main sources of 
folate included in the questionnaire were cereals, beans, legumes, nuts, eggs, meats, 
fishes, bread, edible roots, melons, mushrooms, vegetables and fruits. Similarly, all 
subjects were also asked to provide detailed information about dietary supplements 
consumed in the period of one year before diagnosis or recruitment. For alcohol drinking, 
those who consumed alcohol more than 50 grams each week for more than 6 months were 
defined as “drinkers”. Consumption of all kinds of beverage (beer, alcohol, and wine) was 
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calculated as pure alcohol volume by their alcohol concentrations (%). For smoking, those 
who smoked more than four cigarettes each week in average for more than six months 
were defined as “smokers”. Pack-years were calculated by multiplying the total years of 
smoking by the average packs smoked each day.  
2.3 Genotyping 
DNA was extracted for each subject from the buffy coat fraction with the Promega DNA 
Purification Wizard kit (Promega Co. Madison, WI). Genotyping was performed by the 
polymerase chain reaction restriction-fragments-length polymorphism analysis according to 
methods described previously for MS A2756G (De Marco, Calevo et al. 2002), MTHFR 
C677T (Chen, Giovannucci et al. 1998) and A1298C (Yi, Pogribny et al. 2002), respectively. 
For the MS A2756G polymorphism, a 285-bp PCR product was digested with HaeIII at 37°C 
and visualized after electrophoresis; the genotypes identified were: 265bp for AA, 265bp, 
185bp, 80bp for AG, and 185bp, 80bp for GG. For MTHFR C677T polymorphism, a 198-bp 
PCR product was digested with Hinf I at 37°C and visualized after electrophoresis; the 
genotypes identified as follows: 198bp for CC, 198bp, 175bp, 23bp for CT, and 175bp, 23bp 
for TT. For MTHFR A1298C polymorphism, a 128-bp PCR product was digested with MboII 
at 37°C and visualized after electrophoresis; the genotypes identified were: 72bp, 28bp, 28bp 
for AA, 100bp, 72bp, 28bp for AC, and 100bp, 28bp for CC. The 23bp and 28bp fragments 
had been electrophoresed out of the gel and cannot be seen. Two cases and four controls 
failed to be amplified for MTHFR and MS polymorphisms, possibly due to poor quality of 
DNA. For genotyping quality control, electrophoresis results of genotypes were identified 
by a double-blind check and tested for Hardy-Weinberg equilibrium. Furthermore, 
randomly selected 92 cases and 136 controls were re-genotyped, and there were no 
discrepancies between the original and repeated genotyping results. 
2.4 Statistical analysis 
Energy-adjusted daily folate intake was categorized into quartiles based on the distribution 
in the controls, odds ratios (ORs) and their 95% confidence intervals (CI) were calculated by 
unconditional logistic regression models to estimate the strength of association between 
CRC risk and folate intake, the lowest quartile was used as the reference in OR calculation 
and was further adjusted for sex, age (in years), family cancer history of first degree relatives 
(yes vs. no) and second degree relatives (yes vs. no). Alcohol consumption status was 
divided into four categories based on alcohol (g/d) consumed: non-drinker (0), <30 g/d, 
30~100 g/d, and >100 g/d for estimation of ORs (95% CI), and the drinking status was only 
classified into non-drinker and drinker when exploring the interaction with genotypes. 
Similarly, smoking status was also divided into four categories based on pack years smoked: 
non-smoker (0), ~10, 10~20, and >20 pack years for estimation of ORs (95% CI), and the 
tobacco exposure status was only classified into non-smoker and smoker when exploring 
the interaction with genotypes.  
For evaluating the association between CRC risk and polymorphisms of MS (A2756G) and 
MTHFR (C677T and A1298C) genes, both ORs (95% CI) with and without adjustment for 
sex, age, family cancer history of first and second degree relatives, BMI of 10 years ago 
(divided into 4 subgroups: <20, 20~22.5, 22.5~25.0, >25.0), alcohol drinking and smoking 
status (yes vs. no) were calculated by using unconditional logistic regression models. ORs 
(95% CIs) for gene-gene or gene-environment interactions were assessed on a multiplicative 
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scale in the unconditional logistic regression model with and without adjustment for sex, 
age, family cancer history of first and second degree relatives. When analyzing the joint 
effects of two polymorphisms, we used the combined common genotypes as the reference. 
Hardy-Weinberg equilibrium in the controls was checked for all genotyping data with the  
test, and the exact P value was used to assess any departure of genotypes. 
All statistical analyses were performed by using SAS (version 8.0, SAS institute, Cary, NC), 
with two-sided tests and a significance level of 0.05. 
3. Results 
3.1 Baseline characteristics  
Table 1 shows the characteristics of 478 cases and 838 controls included in the final analysis. 
Overall, the cases were slightly older than the controls with a mean age of 54.3 years for 
cases and 52.0 years for controls. There was no difference in the distributions of sex, 
education, and BMI. However, these differences were further adjusted for their residual 
effects in the later analyses.  
 
 
Variables 
Cases (%) 
N=478 
Controls (%) 
N=838 
Age    
Mean 54.3±12.4 52.0±11.3 
≤50 Years 171 (35.8) 358 (42.7) 
51-60 Years 137 (28.7) 287 (34.3) 
.≥61 Years 170 (35.4) 193 (23.0) 
Gender   
Male 273 (57.1) 462 (55.1) 
Female 205 (42.9) 376 (44.9) 
Educations   
Illiterate 51 (10.7) 75 (8.9) 
Primary, middle school 287 (60.0) 526 (62.8) 
High school 98 (20.5) 151 (18.0) 
College or upper 42 (8.8) 86 (10.3) 
BMI (10 years ago)    
Mean 21.6±2.4 21.6±2.5 
< 20.0 121 (25.3) 216 (25.8) 
20-22.5 200 (41.8) 345 (41.2) 
22.5-25.0 113 (23.6) 207 (24.7) 
> 25.0 44 (9.2) 70 (8.4) 
Table 1. Characteristics of cases and controls in the present study 
3.2 Folate intake, alcohol consumption, genotypes, and CRC risk 
The results of multiple logistic regression analyses of risk of CRC and folate intake, alcohol 
consumption, and tobacco smoking are summarized in Table 2.  
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 Total Male Female  
Environmental 
Factor 
Cases/
Controls
ORa 
(95%CI) 
Cases/
Controls
ORa 
(95%CI) 
Cases/
Controls 
ORa 
(95%CI) 
Folate intake  
(mean, μg/d)  
 
Lowest. (324.0) 188/209 1.00 85/92 1.00 103/117 1.00 
Lower (442.3) 103/210 0.55
(0.40-0.76) 
56/112 0.47
(0.30-0.76) 
47/98 0.60 
(0.38-0.95) 
Middle (522.8) 100/210 0.53
(0.38-0.75) 
64/116 0.52
(0.32-0.84) 
36/94 0.52 
(0.31-0.86) 
Highest (673.7) 87/209 0.46
(0.31-0.67) 
68/142 0.45
(0.28-0.74) 
19/67 0.41 
(0.21-0.82) 
Ptrend= 0.004 0.005 0.002 
Alcohol drinking  
Non-Drinkers 305/612 1.00 116/249 1.00 189/363 1.00 
Light ~30 g/d 75/90 1.99
(1.38-2.88)
60/78 1.93
(1.26-2.95)
15/12 2.69 
(1.20-6.04) 
Moderate ~100 
g/d 
62/89 1.64
(1.10-2.44) 
62/88 1.62
(1.07-2.45) 
0/1 NA 
Heavy >100 g/d 36/47 1.98
(1.21-3.25) 
35/47 1.95
(1.17-3.24) 
1/0 NA 
Ptrend= 0.001 0.002 0.011 
Years of alcohol 
drinking  
 
~5 years 314/624 1.00 123/258 1.00 191/366 1.00 
6~20 years 48/55 2.35
(1.50-3.69) 
41/49 2.30
(1.38-3.81) 
7/6 3.04 
(0.96-9.57) 
20~ years 116/159 1.67
(1.20-2.31) 
109/155 1.58
(1.11-2.23) 
7/4 3.85 
(1.07-13.81) 
Ptrend= 0.001 0.005 0.009 
Smoking  
Non-Smoker 280/521 1.00 77/156 1.00 203/365 1.00 
Light ~10PY 42/78 1.20
(0.75-1.91)
41/71 1.45
(0.88-2.41)
1/7 0.28 
(0.03-2.34) 
Moderate 
10~20PY 
52/75 1.37
(0.87-2.15)
51/73 1.54
(0.96-2.47)
1/2 0.77 
(0.07-8.91) 
Heavy >20PY 104/164 1.26
(0.87-1.83)
104/162 1.40
(0.95-2.07)
0/2 NA 
Ptrend= 0.187 0.087 0.169 
a Adjusted for age, gender, cancer history of first and second degree relatives and total energy intake. 
Table 2. Odds Ratios (95% CI) of CRC associated with folate intake, alcohol consumption 
and smoking   
In the four groups categorized by the quartile of folate intake, the CRC risk decreased 
significantly with the increasing folate intake in a dose-response manner (the same trend 
kept significance in either males or females). Compared with the lowest quartile (a mean 
intake of 324.1 μg/d), the ORs (95% CI) for the lower (442.3 μg/d), middle (522.8 μg/d) and 
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highest (673.7 μg/d) folate intake levels were 0.55 (0.40-0.76), 0.53 (0.38-0.75) and 0.46 (0.31-
0.67), respectively (Ptrend = 0.004), and the same trend kept significance in either males or 
females as described in table 2. Alcohol users had significantly increased CRC risks by nearly 
1.6-2.0 folds higher than those who never drank. The ORs (95% CI) for those who consumed 
alcohol <30g/d, 30-100g/d, and >100g/d were 1.99 (1.38-2.88), 1.64 (1.10-2.44) and 1.98 (1.21-
3.25), respectively (Ptrend=0.001). A longer drinking time was associated with significant 
increased CRC risk (Ptrend=0.001). Compared with those who drank less than five years, those 
who drank 6-20 years or more than 20 years had higher CRC risks with ORs (95% CI) of 2.35 
(1.50-3.69) and 1.67 (1.20-2.31), respectively. However, we did not observe statistical evidence 
of an association between smoking and CRC risk in this study population.  
Table 3 describes the distributions of MS A2756G, MTHFR C677T and A1298C 
polymorphisms and their associations with CRC risk. Those rare MS 2756G genotypes 
carriers had a 1.5 fold increased risk (OR=1.49; 95% CI: 1.11-1.96; Ptrend=0.017), and the same 
trend was observed in the rare homozygous GG carriers though without significant 
difference. However, Both the C677T and A1298C polymorphisms of the MTHFR gene were 
not associated with CRC risk in this study population. We also tested the joint effect or 
locus-locus interaction. By using the combination of any two common genotypes as the 
reference, there were no meaningful interactions between MS A2756G and MTHFR C677T / 
A1298C polymorphisms. 
 
Genotypes Cases (%) Controls (%) ORa (95%CI) ORb (95%CI) 
MS A2756G 
AA 359 (75.4) 688 (82.4) 1.00 1.00 
AG 113 (23.8) 141 (16.9) 1.52 (1.15-2.01) 1.50 (1.13-1.99) 
GG 4 (0.8) 6 (0.7) 1.06 (0.29-3.88) 1.12 (0.30-4.11) 
AG+GG 117( 24.6) 147 (17.6) 1.50 (1.13-1.99) 1.49 (1.11-1.96) 
P trend= 0.009 0.017 
MTHFR C677T 
CC 202 (42.3) 349 (41.9) 1.00 1.00 
CT 210 (43.9) 362 (43.4) 0.97 (0.76-1.25) 0.99 (0.77-1.27) 
TT 66 (13.8) 123 (14.7) 0.90 (0.63-1.28) 0.87 (0.61-1.24) 
CT+TT 276 (57.7) 485 (58.2) 0.96 (0.76-1.21) 0.96 (0.76-1.22) 
P trend= 0.684 0.609 
MTHFR A1298C
AA 295 (62.0) 512 (61.3) 1.00 1.00 
AC 158 (33.2) 282 (33.8) 0.96 (0.75-1.22) 0.96 (0.75-1.22) 
CC 23 (4.8) 41 (4.9) 0.95 (0.55-1.62) 0.96 (0.56-1.65) 
AC+CC 181 (38.0) 323 (38.7) 0.95 (0.75-1.21) 0.96 (0.76-1.21) 
P trend=  0.634 0.766 
a Adjusted for age, gender, cancer history of first and second degree relatives and total energy intake; b 
Adjusted for age, gender, cancer history of first and second degree relatives, total energy intake, BMI of 
10 years ago, alcohol drinking and smoking 
Table 3. CRC risk associated with genotypes of MS and MTHFR gene  
We further evaluated whether the impaction of folate intake on CRC risk was modulated by 
MS and MTFHR genes, alcohol drinking or tobacco smoking as summarized in Table 4.  
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Interactions Cases/ 
Controls 
ORa (95% CI) Cases/ 
Controls 
ORa (95% CI) Pinteraction 
Folate × MS 2756 2756AA  AG+GG   
Lowest 145/179 Ref. 42/28 1.84  
(1.07-3.16) 
 
Lower 74/168 0.55 (0.38-0.79) 29/42 0.84  
(0.49-1.45) 
 
Higher 78/177 0.54 (0.37-0.79) 21/32 0.83  
(0.45-1.53) 
 
Highest 62/164 0.46 (0.30-0.71) 25/45 0.65  
(0.37-1.16) 
0.556 
      
Folate × MTHFR 677 677CC  CT+TT   
Lowest 77/80 Ref. 111/127 0.93  
(0.62-1.41) 
 
Lower 44/88 0.55 (0.33-0.90) 59/122 0.50  
(0.32-0.79) 
 
Higher 36/91 0.43 (0.25-0.72) 64/117 0.58  
(0.36-0.92) 
 
Highest 45/90 0.54 (0.32-1.02) 42/119 0.35  
(0.21-0.60) 
0.629 
      
Folate × MTHFR 
1298 
1298AA  AC+CC   
Lowest 111/138 Ref. 76/69 1.34  
(0.88-2.05) 
 
Lower 66/120 0.69 (0.46-1.04) 37/90 0.50  
(0.31-0.81) 
 
Higher 61/124 0.63 (0.41-0.97) 38/85 0.53  
(0.32-0.87) 
 
Highest 57/130 0.54 (0.34-0.85) 30/79 0.47  
(0.27-0.80) 
0.205 
      
Folate × Drinking Non-
Drinkers 
 Drinkers   
Lowest 134/163 Ref. 54/46 1.63  
(1.00-2.65) 
 
Lower 72/154 0.58 (0.40-0.84) 31/56 0.80  
(0.46-1.38) 
 
Higher 58/159 0.46 (0.31-0.69) 42/51 1.17  
(0.69-1.99) 
 
Highest 41/136 0.39 (0.24-0.62) 46/73 0.86  
(0.52-1.44) 
0.188 
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Interactions Cases/ 
Controls 
ORa (95% CI) Cases/ 
Controls 
ORa (95% CI) Pinteraction 
      
Folate × Smoking Non-
Smokers 
 Smokers   
Lowest 124/144 Ref. 64/65 1.06  
(0.65-1.73) 
 
Lower 67/134 0.57 (0.38-0.85) 36/76 0.55  
(0.32-0.96) 
 
Higher 52/131 0.45 (0.30-0.70) 48/79 0.72  
(0.42-1.21) 
 
Highest 37/112 0.39 (0.24-0.65) 50/97 0.59  
(0.35-1.01) 
0.208 
a Adjusted for age, gender, cancer history of first and second degree relatives, total energy intake and 
also adjusted for smoking status or drinking status, whenever appropriate.  
Table 4. CRC risk associated with interactions between folate intake and genotypes (MS 
A2756G and MTHFR C677T and A1298C) or environmental factors (alcohol and smoke)  
Foalte intake was inversely associated in a dose-dependent manner with CRC risk 
independent of the three genotypes of MS A2756G, MTHFR C677T and A1298C. Results in 
groups stratified by each genotype (common or rare) were similar, though the protective 
effect of folate intake almost disappeared in those carrying rare MS 2756 AG or GG 
genotype; there was no evidence of an interaction between folate intake and each 
polymorphism in a multiplicative model. When non-drinkers having the lowest level of 
folate intake was used as the reference, however, folate intake (from lower to highest) was 
associated with significantly decreasing CRC risk among non-drinkers (OR=0.39, 95% CI: 
0.24-0.62 for the highest level), whereas the significance of protective effect of folate intake 
shown in Table 2 almost disappeared among drinkers who even had the highest level of 
folate intake (OR=0.86, 95% CI: 0.52-1.44); similarly, the protective effect of folate intake 
varied in smokers. Though alcohol drinking or tobacco smoking appeared to have an 
attenuated protective effect of folate intake, we failed to observe a statistically significant 
interaction with either drinking (Pinteraction=0.188) or smoking (Pinteraction=0.208) (Table 4). 
3.3 Gene-environment interaction  
Results of further analyses stratified by alcohol and smoking status are shown in Table 5. 
Here, we did observe a statistically significant interaction between the MS A2756G 
polymorphism and alcohol intake. An increased risk of CRC was observed in those alcohol 
drinkers carrying AG or GG genotype, whereas no significant association with alcohol 
drinking was observed among those carrying the AA genotype (Pinteraction=0.04); Compared 
with non-drinkers carrying MS 2756 AA, the ORs (95% CI) for AG or GG genotype carriers 
who were drinkers of light (~30 g/d), moderate (30~100 g/d) and highest (~100 g/d) level 
were 2.84 (1.44-5.60), 3.14 (1.44-6.83) and 4.40 (1.88-10.32), respectively. We also observed a 
borderline significant interaction between MTHFR A1298C polymorphism and alcohol 
intake (Pinteraction=0.07). For the 1298 AA genotype carriers, the CRC risk of drinkers was 2.0- 
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Interactions 
Case/ 
Control 
ORa (95% CI) 
Case/ 
Control
ORa (95% CI) Pinteraction 
MS 2756 2756AA  AG+GG   
MS 2756×Drinking      
Non-Drinker 242/502 1.00 62/107 1.19 (0.83-1.71)  
Light ~30 g/d 52/73 1.83 (1.20-2.78) 22/17 2.84 (1.44-5.60)  
Moderate ~100 g/d 44/76 1.43 (0.92-2.24) 18/13 3.14 (1.44-6.83)  
Heavy >100 g/d 21/37 1.46 (0.81-2.63) 15/10 4.40 (1.88-10.32) 0.041 
      
MS 2756×Smoking      
Non-Smoker 224/427 1.00 55/91 1.13 (0.77-1.65)  
Light ~10PY 32/62 1.16 (0.70-1.95) 10/16 1.40 (0.60-3.28)  
Moderate 10~20PY 37/61 1.25 (0.76-2.06) 15/14 1.95 (0.87-4.35)  
Heavy >20PY 66/138 0.96 (0.64-1.45) 37/26 2.90 (1.61-5.22) 0.006 
      
MTHFR 677 677CC  CT+TT   
MTHFR 677×Drinking      
Non-Drinker 133/250 1.00 172/358 0.89 (0.671.18)  
Light ~30 g/d 29/47 1.39 (0.81-2.39) 46/43 2.32 (1.42-3.82)  
Moderate ~100 g/d 25/32 1.80 (0.97-3.31) 37/57 1.36 (0.82-2.25)  
Heavy >100 g/d 15/20 1.83 (0.87-3.82) 21/27 1.82 (0.95-3.47) 0.780 
      
MTHFR 677×Smoking      
Non-Smoker 130/214 1.00 150/304 0.81 (0.60-1.09)  
Light ~10PY 18/36 0.96 (0.50-1.83) 24/42 1.14 (0.62-2.09)  
Moderate 10~20PY 16/39 0.78 (0.39-1.54) 36/36 1.63 (0.92-2.89)  
Heavy >20PY 38/60 1.17 (0.69-1.98) 66/103 1.10 (0.70-1.72) 0.268 
      
MTHFR 1298 1298AA  AC+CC   
MTHFR 1298×Drinking      
Non-Drinker 179/375 1.00 125/234 1.14 (0.85-1.52)  
Light ~30 g/d 46/50 2.40 (1.51-3.81) 28/40 1.66 (0.85-2.88)  
Moderate ~100 g/d 46/59 1.97 (1.23-3.14) 16/30 1.22 (0.61-2.44)  
Heavy >100 g/d 24/28 2.39 (1.30-4.42) 12/19 1.64 (0.75-3.57) 0.069 
      
MTHFR 1298×Smoking      
Non-Smoker 165/323 1.00 114/195 1.09 (0.81-1.49)  
Light ~10PY 27/42 1.50 (0.85-2.66) 15/36 0.92 (0.46-1.82)  
Moderate 10~20PY 34/45 1.46 (0.84-2.51) 18/30 1.32 (0.67-2.60)  
Heavy >20PY 39/102 1.38 (0.89-2.13) 34/62 1.12 (0.66-1.89) 0.377 
a Adjusted for age, cancer history of first and second degree relatives and total energy intake, smoking 
status or drinking status, whenever appropriate.  
Table 5. CRC risk associated with interactions between genotypes (MS A2756G and MTHFR 
C677T and A1298C) and environmental factors (drinking and smoking)  
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2.4 folds of non-drinkers; however, for those carrying 1298 AC or CC genotype, alcohol 
drinking was non-significantly associated with CRC risk, compared with non-drinkers 
carrying the 1298 AA genotype (Table 5).  
We also tested the gene-smoking interaction. The patterns of risk associated with MS 
A2756G genotypes seemed to vary by smoking status. For example, smoking was found to 
be associated with significantly increased CRC risk in MS 2756G carriers but not in 2756AA 
carriers, and there was evidence of an interaction (Pinteraction=0.006). Compared with non-
smokers carrying the AA genotype, an OR of 2.90 (1.61-5.22) was observed for those with 
AG or GG genotype and the highest smoking level (>20 pack-years). However, there were 
no evidence of an interaction between the genotypes of MTHFR C677T or A1298C and 
smoking (Table 5). 
4. Discussion 
4.1 Folate intake, alcohol drinking, MS A2756G polymorphism and CRC risk  
Folate is traditionally regarded as a protective factor for CRC, and many studies have 
reported a beneficial role in reducing CRC risk, especially in some large-scale case-control or 
cohort studies (Giovannucci 2002; Terry, Jain et al. 2002; Sanjoaquin, Allen et al. 2005; 
Strohle, Wolters et al. 2005; Kennedy, Stern et al. 2011), but in recent years some clinical 
intervention trials have raised the controversy that an increased CRC risk may be produced 
when folate, especially fortified or supplemental folic acid (synthetic), was administered in 
an excessive dose and was inopportunely administered when there has some existing 
lesions (such as undetectable small cancer or precursors) (Strohle, Wolters et al. 2005; 
Hubner and Houlston 2009; Sauer, Mason et al. 2009). Nonetheless, there is no confirmative 
evidence against the hypothesis that the loss of homeostasis of folate-mediated one-carbon 
metabolism can cause abnormal DNA methylation or DNA misincorporation, thus resulting 
in colorectal neoplasia, but some studies argued that the folate (natural or synthetic) per se 
can indeed contribute to the reduction of CRC risk (Bollheimer, Buettner et al. 2005; Strohle, 
Wolters et al. 2005; Kim 2007; Sauer, Mason et al. 2009). The present study investigated the 
association between folate intake and the risk of CRC in a Chinese population, in which no 
one had the habit of daily use of any vitamin supplement; therefore, the “folate intake” 
evaluated in this study means only from natural food, and our results showed a significant 
association between higher folate intake and lower CRC risk (Table 2). Such a protective 
effect did not change substantially before and after multivariate adjustment, even in 
subgroups of colon or rectal cancer (data not shown). Therefore, the present study, generally 
consistent with many previously published reports (Giovannucci 2002; Terry, Jain et al. 
2002; Sanjoaquin, Allen et al. 2005; Kennedy, Stern et al. 2011), provides a further insight 
and a support for an inverse association between folate (from food) intake and CRC risk in 
Chinese populations.  
Although folate intake alone showed a significant protection against CRC risk, the variation 
in MS and MTHFR genes may also play important roles in the folate-mediated methyl 
cycles, and both alcohol drinking and cigarette smoking are known to impair the absorption 
and biological actions of folate. Although there was no evidence for an interaction in the 
present study, there was a trend that the protective effect of the folate appeared to be more 
obvious in those who were not exposed to the known risk factors drinking or smoking) 
compared with those who were exposed; in fact, the significant inverse association between 
folate intake and CRC risk was observed in 2756AA carriers or non-drinkers (non-smokers) 
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but not in either 2756G carriers or drinkers (or smokers). It seems that, to some extent, the 
favourable effect of folate may be impaired by the MS 2756G allele or drinking (or smoking), 
a finding consistent with other published studies (Kim 2007; Kim 2007). However, because 
our study was relatively small, larger studies, especially in Chinese populations, are needed 
to validate such an interaction between folate intake and MS 2756 AG+GG genotypes or 
drinking (smoking).  
4.2 Gene polymorphisms and CRC risk 
Several studies have investigated the association between the MS 2756 A>G polymorphism 
and CRC risk but generated conflicting results (Chen, Giovannucci et al. 1998; Ma, Stampfer 
et al. 1999; Goode, Potter et al. 2004; Ulvik, Vollset et al. 2004; Matsuo, Ito et al. 2005; Ulrich, 
Curtin et al. 2005; Koushik, Kraft et al. 2006; Theodoratou, Farrington et al. 2008; Yamaji, 
Iwasaki et al. 2009; Yu, Zhang et al. 2010). Using the common AA genotype as the reference, 
four studies reported no overall effect but a non-significantly association between CRC risk 
and the 2756G genotypes (Koushik, Kraft et al. 2006; Theodoratou, Farrington et al. 2008; 
Yamaji, Iwasaki et al. 2009). Recently, a Japanese study and an American study with 
257/771 and 513/609 cases/controls, respectively, also supported the trend that the MS 
2756G genotypes can elevate the risk of colorectal cancer or adenomas (Goode, Potter et al. 
2004; Matsuo, Ito et al. 2005). One population-based case-control study of colon, but not 
rectal, cancer found no association (Ulrich, Curtin et al. 2005); only two earlier studies (one 
cancer and one adenomas) found significantly reduced risk among AG or GG carriers 
(Chen, Giovannucci et al. 1998; Ma, Stampfer et al. 1999), and one large-scale nested case-
control study reported an inverse association between the G allele and CRC risk in 
Norwegians (Ulvik, Vollset et al. 2004). The present study was the first to explore the effect 
of the MS polymorphism on CRC risk in a Chinese population, and we found that the MS 
2756 AG or GG genotypes were significantly associated with increased risk of CRC, further 
supporting a positive association between rare 2756 AG or GG genotypes and CRC risk.  
We also observed another interesting finding that the frequency of the MS 2756G allele 
(9.2%) among controls was materially different from those (15%~20%) among different 
ethnic populations reported by other studies, and the frequency of 2756GG genotype in our 
study was less than 1% in both cases and controls, much lower than 3%-5% in other 
populations, such as Americans, Europeans and other Asia populations of Japanese or 
Hindoo (Goode, Potter et al. 2004; Ulvik, Vollset et al. 2004; Chen, Jiang et al. 2005; Matsuo, 
Ito et al. 2005; Ulrich, Curtin et al. 2005; Koushik, Kraft et al. 2006; Diwakar, Rudresh Kumar 
et al. 2008; Theodoratou, Farrington et al. 2008; Yamaji, Iwasaki et al. 2009). However, our 
results, especially for the frequencies of AG and GG genotypes among controls, were very 
similar to other studies in Chinese populations that investigated the association between the 
MS A2756G polymorphism and Alzheimer disease or lung cancer, in which the G allele 
frequency for controls was 8.5% and 9.8%, respectively (Liu, Jin et al. 2008; Zhao, Li et al. 
2008). Therefore, it is likely that the allele frequency of the 2756G in Chinese is quite 
different from that of western or other Asia populations such as Japanese or Hindoo. It is 
still unclear whether the MS 2756A>G polymorphism has any functional consequences in its 
enzyme activity, but it was suggested that this polymorphism may probably decrease the 
enzyme activity, since the polymorphic site lies in a region connecting the vitamin B12 
binding domain and the activation domain (Matthews, Sheppard et al. 1998). Considering 
epidemiologic evidence and the rare 2756G allele frequency in Chinese populations, our 
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findings suggested this variant may play a role in the etiology of CRC in Chinese 
populations, possibly a risk factor of CRC for Asia populations, in contrast to a protective 
effect in other ethnic populations. However, this finding needs to be further validated in 
larger studies of Asia populations. 
In the present study we found that MTHFR 677 or 1298 variants were non-significantly  
associated with decreased CRC risk which is consistent in trend with other earlier 
epidemiological studies (Chen, Giovannucci et al. 1996; Ulvik, Vollset et al. 2004; Matsuo, Ito 
et al. 2005; Huang, Han et al. 2007; Kim 2007). The frequencies of 677T or 1298C alleles in 
our controls were very close to those of other Chinese populations and different Asia 
populations, such as Japanese or Korean, although the 1298C allele frequency was a slightly 
lower compared with western white populations (Chen, Jiang et al. 2005; Matsuo, Ito et al. 
2005; Kim 2007). Laboratory evidence suggested that the rare 677T or 1298C allele can result 
in decreased enzyme activity in vitro (Molloy, Daly et al. 1997; Weisberg, Jacques et al. 2001) 
which seemed to favor an increased CRC risk, but on the contrary, most reported studies 
have not found an significant association between these MTHFR polymorphisms and CRC 
risk, and some earlier studies even reported an inverse association especially in white 
populations that were likely to have a relatively higher average total folate intake, partly 
due to use of vitamin supplements (Chen, Giovannucci et al. 1996; Ma, Stampfer et al. 1997). 
One-carbon unit metabolism may depend on a series of enzymatic steps forming a complex 
biochemical network, in which multiple dietary or environmental factors (e.g., vitamin B2, 
B12, and alcohol) may interact with folate, therefore the genetic variations of the MTHFR 
gene alone might not be sufficient to influence colorectal tumorigenesis during the one-
carbon unit metabolism. Larger studies are required to further evaluate gene-gene and gene-
environment interactions in the association between MTHFR C677T or A1298C 
polymorphisms and CRC risk in Chinese populations.  
4.3 Gene-environment interactions and CRC risk 
Though our study was relatively smaller, we did find some evidence of interactions between 
the MS A2756G polymorphism and three environmental factors (folate intake, alcohol use, 
and tobacco smoking) in the CRC etiology. Our study provided the first report of an effect of 
the MS 2756 A>G polymorphism and its interactions with dietary folate intake, alcohol 
consumption or cigarette smoking on CRC risk in a Chinese population.  
Epidemiological studies have linked heavy alcohol use to increased risk of CRC,   
(Giovannucci 2002; Cho, Smith-Warner et al. 2004). Because alcohol can break the folate or 
disturb the one-carbon unit metabolism and thus may cause abnormal DNA methylation, 
DNA repair, or increase the activation of precarcinogen in liver by inducing cytochrome p-
450 (Giovannucci 2004; Sharp and Little 2004), drinkers carrying rare MS 2756G, MTHFR 
677T or 1298C alleles may have additional CRC risk caused by abnormal folate metabolism 
(Giovannucci 2002; Sharp and Little 2004; Matsuo, Ito et al. 2005; Yamaji, Iwasaki et al. 2009). 
Our results supported  such an association as well as a possible interaction between these 
polymorphisms and alcohol use in CRC risk.  
Cigarette smoking may play a role in CRC but is not a major recognized risk factor, even 
after a long period of exposure (Giovannucci 2001; Anderson, Attam et al. 2003), and this 
was also true in the present study. However, we found an interaction between MS A2756G 
genotypes and smoking; compared with non-smokers carrying the MS 2756AA genotype, 
the AG or GG carriers of heavy smokers (>20 pack-years) had a 3-fold increased CRC risk. It 
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was reported that MTHFR 677T allele caused an increased plasm homocysteine 
concentration in heavy smokers than in moderate or non-smokers (Brown, Kluijtmans et al. 
2004), and other studies found that an interaction between smoking and MTHFR C677T 
genotypes can be determinants of adenomatous and hyperplastic polyps of colorectum 
(Ulvik, Evensen et al. 2001). In the present study, however, we did not find any evidence of 
an interaction between smoking and MTHFR C677T or A1298C genotypes.  
Overall, as Hubner mentioned very recently (Hubner and Houlston 2009), the existing 
evidence is still insufficient to confirm a protective effect of folate intake, and variants of the 
key metabolic-enzyme genes add the complexity to the unresolved problem of how and 
when the folate can have an effect on CRC risk. Our results suggested that gene-
environment interactions may affect CRC risk more profoundly than the individual effect of 
folate intake or any of other known risk factors in this study population.  
There are some potential limitations in the present study. First of all, because we did not 
have serum levels of folate or homocysteine, there may be biases in categorizing actual 
folate intake levels that were solely based on questionnaire data. Second, this hospital-based 
case-control study may have introduced some unknown selection biases. However, we 
reasonably believe that our cases and controls came from the same population base served 
by the hospitals, because all cases were newly diagnosed and most of controls were also 
registered at hospitals for the first time. Third, there was inherent recall bias in case-control 
studies; however, our interviewers did not know case-control status of the subjects. Lastly, 
our relatively smaller sample size may not have sufficient study power to detect interactions 
among folate, alcohol, smoking and the studied genotypes on CRC risk. 
5. Conclusion 
The present study suggested that sufficient folate intake may reduce the risk of CRC, and 
alcohol use can significantly increase CRC risk in the study population. The MS 2756 
AG+GG genotypes may be associated with an increased CRC risk; our data further 
suggested that the interaction between MS 2756 A>G polymorphism and alcohol use may 
result in further increased CRC risk in this Chinese populations. How and to what extent 
can these joint effects modify the CRC risk need additional larger epidemiological studies 
especially in other Chinese populations. 
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